Analysis of the clonal and subclonal mutations in a large CLL series revealed that SF3B1 mutations are typically detected as subclonal mutations, particularly in early-stage samples, and hence likely to be a later event in the progression of CLL [26]. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.